Allplex™ RV Master Assay

Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.

A rapid and accurate Point-of-Care diagnostic test for influenza and RSV detection. It enables multiplex respiratory viral testing at the point-of-care. Available variants: VitaPCR™ Flu/RSV Assay.

Molecular diagnostic assay for respiratory syncytial virus detection. Provides reliable and accurate identification of RSV infections with strong analytical performance.

Molecular diagnostic assay for detecting pathogens causing lower respiratory tract infections. Provides comprehensive identification of causative agents.

A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.

Multiplex PCR-based assay designed to simultaneously identify viral-bacterial and viral-viral co-infections in respiratory tract samples for comprehensive pathogen identification.

Multiplex RT-PCR assay for detection of respiratory pathogens. This test simultaneously identifies multiple viral and bacterial agents responsible for respiratory infections.

Real-time PCR kit for detection and differentiation of four respiratory viruses: influenza A and B, SARS-CoV-2, and respiratory syncytial virus. This multiplex assay enables rapid identification of major respiratory pathogens in clinical samples.

A comprehensive multiplex PCR assay for detecting 12 common respiratory tract infection pathogens. It provides rapid, efficient, and accurate detection of respiratory pathogens for disease prevention and clinical diagnosis.

A diagnostic test that simultaneously detects herpes simplex virus types 1 and 2, and varicella-zoster virus. The multiplex assay is designed to maximize use of standard laboratory equipment for sexually transmitted infection diagnosis.

Utilizes Colloidal Gold Immunochromatographic Assay and Fluorescence Immunoassay technologies to support rapid antigen detection for Influenza A/B, RSV, COVID-19, ADV, HMPV, PIV, and co-infection panels. Designed for professional point-of-care testing (POCT) environments in hospital emergency departments and public health programs. Compatible with nasopharyngeal and nasal swab samples with CE-IVD compliant formats and shelf life up to 36 months at 2–30°C.

Rapid lateral flow assay for simultaneous detection of three respiratory pathogens commonly associated with lower respiratory tract infections. Supports differential diagnosis of respiratory infections.